Autoinjector preference among patients with multiple sclerosis: results from a national survey

PURPOSE: Autoinjectors are well-established in supporting multiple sclerosis (MS) therapy. This market survey was aimed at investigating patients’ rating of three devices for subcutaneous interferon beta formulations: the electronic autoinjectors Betaconnect(®) and RebiSmart™ as well as the mechanic...

Descripción completa

Detalles Bibliográficos
Autores principales: Limmroth, V, Reischl, J, Mann, B, Morosov, X, Kokoschka, A, Weller, I, Schreiner, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548304/
https://www.ncbi.nlm.nih.gov/pubmed/28831243
http://dx.doi.org/10.2147/PPA.S137741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548304/
https://www.ncbi.nlm.nih.gov/pubmed/28831243
http://dx.doi.org/10.2147/PPA.S137741

Ejemplares similares